Business Insider: Global Radiotherapy Markets to 2025: External Beam Radiotherapy Market Poised to Reach Over US$3.6 Billion Global Radiotherapy Markets to 2025: External Beam Radiotherapy Market Poised to Reach Over US$3.6 Billion ascopubs.org: External beam radiotherapy for laryngeal cancer and risk for second primary thyroid carcinoma: A SEER database analysis External beam radiotherapy for laryngeal cancer and risk for second primary thyroid carcinoma: A SEER database analysis Nature: High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with ... High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with ... ascopubs.org: Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells.

Context Explanation

After enough damage, the cells cannot multiply, and they die.